Trading Conditions

Platform
MT5
MT5
Execution
Market Execution
Market Execution
MT5Floating spreads
Minimum: 5.00Average: 5.52
Market Hours*Closed Now
Market Hours*Closed Now
TickerVERV.O
Limit and Stop Level10
1 tick value per share0.01 USD
Minimum contract size0.01 share
CommissionNo
Minimum Price Fluctuation0.01 USD
Minimum step for increasing contract size0.01 share
Margin requirements to open a lock position *0
Maximum Trade Size1000
Maximum exposure per share per account, USD100 000
Commissions & Swap Charges
Leverage
Corporate Actions

* Only if Margin Level > 100%

The average spreads provided for each platform are updated on a daily basis to reflect the average for the previous day. Though FxPro attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. FxPro has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions of Business'.

Explore the dynamic world of Verve Therapeutics Inc shares on FxPro. Get the latest information on the current share price, market performance, and economic insights. Understand Verve Therapeutics Inc's market position with our comprehensive analysis, including historical data and future prospects. Stay informed about the latest market trends and how they impact Verve Therapeutics Inc's share value. Start trading with FxPro today and leverage the potential of Verve Therapeutics Inc's shares in your investment portfolio.

Founded in 2018, Verve Therapeutics Inc is a biotech company specialising in gene-editing techniques for the treatment of coronary arteries and cardiovascular diseases.

The first two VERV.O programs target PCSK9 and ANGPTL3, two genes that have been confirmed by human genetics and pharmacology as markers for lowering blood lipids. The company completed its initial public offering on the Nasdaq in June 2021, generating $266.7 million in gross revenue.

Verve Therapeutics Inc stock has had increased awareness and popularity among investors recently. FxPro clients can buy and also sell this asset as a CFD, speculating on the price changes.

On the page above, there is an online quote chart, as well as trading conditions applicable to this security.

For effective trading on the stock market, we recommend you check the stock prices regularly. Also, follow the corporate reports and news about the company's activities that are published on major analytical portals.

One of the most important things to pay attention to is upcoming earnings releases and dividend payment dates. You can check the monthly schedule on the Dividend & Earnings Calendar on the FxPro website. If you have a Buy position open on the ex-dividend date, your trading account will be credited with the dividend net of any withholding taxes. In the case of holding a Sell position, the whole dividend will be debited from your account. If you have questions about this, our customer support team are on hand to assist.

Start Trading VERV.O CFD Stocks with FxPro Today!

Why trade with FxPro

22+ Years of Excellence

Choose a trusted broker that serves clients in over 170 countries.

Trade thousands of Instruments

Trade CFDs on Forex, Shares, Futures, Spot Indices, Spot Metals and Spot Energy.

4 Trading Platforms

Trade on your preferred platform including FxPro MT4, MT5, cTrader and Edge

Fast Execution & Deep Liquidity

Benefit from ultra-fast order execution with most orders executed in under 13 ms.

105+ UK & International Awards

Trade with a broker that has been repeatedly recognized for the quality of its services.

24/5 Multilingual Support

Reap the benefits of our 24/5 Customer Support, providing assistance in more than 17 languages.

Start Trading Now or Try Demo Account

Practise like a Pro!